Lupin: The company announced that it has received approval for its Droxidopa capsules, 100 mg, 200 mg & 300 mg from United States Food & Drug Administration (USFDA), to market a generic equivalent of Northera capsules, 100 mg, 200 mg & 300 mg of Lundbeck NA Ltd.